Abstract:We report the development of novel cannabinergic probes that can stabilize the cannabinoid receptors (CBRs) through tight binding interactions. Ligand design involves the introduction of select groups at a judiciously chosen position within the classical hexahydrocannabinol template (monofunctionalized probes). Such groups include the electrophilic isothiocyanato, the photoactivatable azido, and the polar cyano moieties. These groups can also be combined to produce bifunctionalized probes potentially capable of interacting at two distinct sites within the CBR-binding domains. These novel compounds display remarkably high binding affinities for CBRs and are exceptionally potent agonists. A key ligand (27a, AM11245) exhibits exceptionally high potency in both in vitro and in vivo assays and was designated as "megagonist," a property attributed to its tight binding profile. By acting both centrally and peripherally, 27a distinguishes itself from our previously reported "megagonist" AM841, whose functions are restricted to the periphery.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c02053?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02053</a>.Experimental procedures, spectroscopic, analytical, and physical data for 12a–b, 13a–b, 14a–c, 15a–c, 16a–c, 17a–c, 18a–c, 19a–c, 20a–c, 21a–c, 22a–c, 23a–c, 24a–c, 25a–c, 26a–c, and 27a–c; saturation binding curves using [3H]CP-55,940 for CB1 and CB2 receptors pre-incubated with the 25a–c, 26a–c, 27a–c, 31c, 32c, 33c, and 34c; and HPLC traces of 25a, 26c, 27b, and 31c (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02053/suppl_file/jm0c02053_si_001.pdf">PDF</a>).Molecular formula strings and biochemical data of 25a–c, 26a–c, 27a–c, 31c, 32c, 33c, and 34c (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02053/suppl_file/jm0c02053_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Crystal Structure of the Human Cannabinoid Receptor CB2

Crystal Structure of the Human Cannabinoid Receptor CB1

Modeling, Molecular Dynamics Simulation, and Mutation Validation for Structure of Cannabinoid Receptor 2 Based on Known Crystal Structures of GPCRs

Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex

Crystal structures of agonist-bound human cannabinoid receptor CB1

Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures

Design, syntheses, structure-activity relationships and docking studies of coumarin derivatives as novel selective ligands for the CB2 receptor.

The progress of small molecules against cannabinoid 2 receptor (CB2R)

Structure of an allosteric modulator bound to the CB1 cannabinoid receptor

Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists

High-resolution crystal structure of the human CB1 cannabinoid receptor

Structural and Functional Insights into Cannabinoid Receptors

Structural Insights into CB1 Receptor Biased Signaling

Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists

Methods for recombinant expression and functional characterization of human cannabinoid receptor CB2

Expression, Purification and Characterization of the Human Cannabinoid 1 Receptor

Ligand-specific homology modeling of human cannabinoid (CB1) receptor

Large library docking for cannabinoid-1 receptor agonists with reduced side effects

Computational Investigation on the Binding Modes of Rimonabant Analogs with CB1 and CB2

Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1